| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9523 |
| Human Intestinal Absorption | HIA+ | 0.9885 |
| Caco-2 Permeability | Caco2+ | 0.8911 |
| P-glycoprotein Substrate | Non-substrate | 0.8489 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9902 |
| Non-inhibitor | 0.9939 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9132 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6401 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8003 |
| CYP450 2D6 Substrate | Non-substrate | 0.9585 |
| CYP450 3A4 Substrate | Non-substrate | 0.8301 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7296 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9611 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9057 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9632 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9691 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9848 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9708 |
| Non-inhibitor | 0.9869 |
| AMES Toxicity | Non AMES toxic | 0.9867 |
| Carcinogens | Non-carcinogens | 0.6082 |
| Fish Toxicity | High FHMT | 0.7216 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8756 |
| Honey Bee Toxicity | High HBT | 0.7118 |
| Biodegradation | Ready biodegradable | 0.8973 |
| Acute Oral Toxicity | III | 0.7905 |
| Carcinogenicity (Three-class) | Non-required | 0.7428 |